WO1998017290A1 - Agent therapeutique utilisant une combinaison d'huiles essentielles, applique localement pour soulager la douleur - Google Patents

Agent therapeutique utilisant une combinaison d'huiles essentielles, applique localement pour soulager la douleur Download PDF

Info

Publication number
WO1998017290A1
WO1998017290A1 PCT/AU1997/000715 AU9700715W WO9817290A1 WO 1998017290 A1 WO1998017290 A1 WO 1998017290A1 AU 9700715 W AU9700715 W AU 9700715W WO 9817290 A1 WO9817290 A1 WO 9817290A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
therapeutic agent
pain
formulation
base oil
Prior art date
Application number
PCT/AU1997/000715
Other languages
English (en)
Inventor
Peter Mcmurtrie
Original Assignee
Mcprint Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcprint Pty. Ltd. filed Critical Mcprint Pty. Ltd.
Priority to AU46113/97A priority Critical patent/AU714139B2/en
Publication of WO1998017290A1 publication Critical patent/WO1998017290A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon

Definitions

  • THIS INVENTION relates to a therapeutic agent which is an
  • relieving function and such massage oils include a sunflower oil or mineral
  • avocado oil eucalyptus oil, jasmine, rosemary, lavender, boronia, rose,
  • flavouring agents in the form of flavouring agents or spices, fragrances or in
  • cosmetics and such essential oils include allspice (pimenta berry), bitter
  • sweet birch bois de rose (rosewood), camphor, cananga, caraway,
  • ocotea bitter orange, sweet orange, origanum, orris root, palmarosa, patchouli, black pepper, peppermint, petitgrain bigarade, pine, pinus
  • eucalyptus oil may be mixed together and combined with eucalyptus oil or any one of
  • base oil such as liquid alkane, long chain hydrocarbons,
  • vegetable oils inclusive of safflower oil, coconut oil, peanut oil, almond oil
  • liquid petrolatum and palm oil and liquid petrolatum.
  • liquid petrolatum and palm oil and liquid petrolatum.
  • liquid paraffin or mineral oil is the major base oil
  • Capric triglyceride may also be utilized.
  • preparation is externally or topically applied to an area of the body
  • An emulsifying agent may be added which includes arabic gum, xanthan gum and tragacanth gum based on
  • spike lavender oil also refers to the optional use of spike lavender oil as a perfume.
  • each of the fragrant oils when used individually are not known for use as a
  • the invention therefore includes a therapeutic agent
  • each leg comprising in combination oil of spike, lavender and myrrh.
  • each leg comprising in combination oil of spike, lavender and myrrh.
  • a base oil which may be selected from liquid
  • alkanes or long chain hydrocarbons which have 10-25 carbon atoms and
  • Such long chain hydrocarbons may be more preferably 14-22 carbon atoms.
  • Such long chain hydrocarbons may be any long chain hydrocarbons.
  • the base oil may also include
  • vegetable oils inclusive of safflower oil, coconut oil, peanut oil, soybean oil, almond oil, palm oil or capric triglyceride.
  • a mineral oil such as
  • a preferred base oil is a blend of vegetable oils and
  • a desirable base oil has been found to be a product
  • the ingredients of this base oil comprise 33% almond oil, 23% apricot
  • Oil of orange is an oil expressed from fresh peel of ripe fruit
  • Oil of orange is a yellow to deep orange liquid with
  • Oil of orange has a specific gravity at 25°C of 0.842 - 0.846.
  • limon L.) Rutaceae It comprises 90% of limonene, terpinene,
  • citral, citronellal, geranyl acetate and sesquiterpenes It is mainly used as
  • flavouring agent and also utilized in perfumes.
  • Lemon oil has a specific gravity at 25°C of 0.849-0.855 and
  • the constituents of myrrh comprise 20-25% resin,
  • myrrh oil has a
  • the oil derived from spike or oil of spike lavender is a
  • This oil comprises about 35% eucalyptol, camphor, linalool,
  • Oil of spike lavender is a liquid which has a slightly pale yellow colour. It has a specific gravity at 20°C of 0.8830 minimum and
  • oil of lemon utilized in the therapeutic agent of the invention is from 0.1-
  • one drop is approximately equal to 0.03 ml.
  • FIG. 1 shows spectra of a therapeutic product of the
  • FIG. 2 shows spectra of the base oil used in the therapeutic
  • FIG. 3 shows spectra of spike lavender oil which has been
  • FIG. 4 shows spectra of myrrh oil analysed by GCMS (gas
  • FIG. 5 shows spectra of lemon oil analysed by GCMS (gas
  • the therapeutic agent of the invention in clinical trials has
  • ARO-MAS base oil as hereinbefore described was utilised in various
  • patellae (knees) and has had this pain for the last 15 years.
  • the pain was caused by operations and she was left to walk with the help of a frame
  • PATIENT D A male, aged 15, played rugby union and broke his wrist
  • the formulation was applied to the ankle by massaging. The
  • a female, aged 35, has a high pressure job in business

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Agent thérapeutique qui comprend une combinaison d'huile de lavande aspic et d'huile de myrrhe, utilisées dans des quantités efficaces du point de vue thérapeutique avec une huile de base qui sert d'excipient.
PCT/AU1997/000715 1996-10-23 1997-10-23 Agent therapeutique utilisant une combinaison d'huiles essentielles, applique localement pour soulager la douleur WO1998017290A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU46113/97A AU714139B2 (en) 1996-10-23 1997-10-23 Topically applied therapeutic agent for pain relief using a combination of essential oils

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO3148 1996-10-23
AUPO3148A AUPO314896A0 (en) 1996-10-23 1996-10-23 Therapeutic agent

Publications (1)

Publication Number Publication Date
WO1998017290A1 true WO1998017290A1 (fr) 1998-04-30

Family

ID=3797457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1997/000715 WO1998017290A1 (fr) 1996-10-23 1997-10-23 Agent therapeutique utilisant une combinaison d'huiles essentielles, applique localement pour soulager la douleur

Country Status (2)

Country Link
AU (1) AUPO314896A0 (fr)
WO (1) WO1998017290A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846240A1 (fr) * 2002-10-24 2004-04-30 Maria Yolanda Aliaga Onguent pour le corps, concu pour soulager et faire disparaitre progressivement les douleurs musculaires, foulures, entorses, deboitements, descongestionnants et pour apaiser les douleurs articulaires et rhumatismales.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044057A (en) * 1975-12-29 1977-08-23 Monsanto Company Aroma chemicals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044057A (en) * 1975-12-29 1977-08-23 Monsanto Company Aroma chemicals

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A MODERN HERBAL, M. GRIEVE, Published by PENGUIN BOOKS in 1988, pages 469-473, 571-572. *
DERWENT ONLINE, Acc. No. 92-22343; & JP,A,04 149 136 (KUREHA CHEM. IND. CO. LTD.), 22 May 1992. *
ENCYCLOPEDIA OF COMMON NATURAL INGREDIENTS, 2nd Ed., Published by WILEY AND SONS INC., 1996, pages 339-334 and page 382. *
NATURE, Vol. 379, No. 4, January 1996, DOLARA et al., "Analgesic Effects of Myrrh", page 29. *
NURSING TIMES, Vol. 89, No. 20, 19 May 1993, J. BUCKLE, pages 32-35. *
ZEITSCHRIFT FUER NATURFORSCHUNG, Vol. 46, Nos. 11-12, November-December 1991, BUCHHAUER et al., pages 1067-1072. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2846240A1 (fr) * 2002-10-24 2004-04-30 Maria Yolanda Aliaga Onguent pour le corps, concu pour soulager et faire disparaitre progressivement les douleurs musculaires, foulures, entorses, deboitements, descongestionnants et pour apaiser les douleurs articulaires et rhumatismales.
EP1516631A1 (fr) * 2002-10-24 2005-03-23 Maria Yolanda Aliaga Onguent, pour le corps à effets décongestionnant et faire disparaitre progressivement les douleurs musculaires, foulures, entorses, déboitements, courbatures et apaiser les douleurs articulaires et rhumatismales

Also Published As

Publication number Publication date
AUPO314896A0 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
Lis-Balchin Aromatherapy science: a guide for healthcare professionals
Lawless The Encyclopedia of essential oils: the complete guide to the use of aromatic oils in aromatherapy, herbalism, health, and well being
Sellar The directory of essential oils
US11446278B2 (en) Penetrating topical pain relief compositions and methods of use
WO2013048235A2 (fr) Pommade à base d'herbes médicinales
US20050214244A1 (en) Menopause homeopathic formulations
US20190151232A1 (en) Topical Compositions, Process of Manufacture and Method of Use
ES2264421T3 (es) Composicion terapeutica basada en oregano.
CN106309165A (zh) 一种植物精油护肤霜及其制备方法
US11564963B2 (en) Topical compositions, process of large-scale manufacture, and method of use
US20080145461A1 (en) Formulation and method of making a topical pain relief composition
Stiles The essential oils complete reference guide: Over 250 recipes for natural wholesome aromatherapy
WO2001005416A1 (fr) Huile extraite de momordica charantia-l., son procede de fabrication et ses utilisations
US11839593B2 (en) Penetrating topical pain relief compositions and methods of use
CN105943557B (zh) 一种抗风湿关节炎乳膏组合物及其制备方法
WO2021236108A1 (fr) Compositions topiques, procédé de fabrication à grande échelle et méthode d'utilisation
US20140178487A1 (en) Camel hump oil - based herbal compositions and method of making the same
AU714139B2 (en) Topically applied therapeutic agent for pain relief using a combination of essential oils
WO1998017290A1 (fr) Agent therapeutique utilisant une combinaison d'huiles essentielles, applique localement pour soulager la douleur
US11559499B1 (en) Lotion and tinctures containing CBD oil including preparation and use thereof
JP2005023044A (ja) 香気剤
AU2021106893A4 (en) Topical Compositions
US12029707B2 (en) Penetrating topical pain relief compositions and methods of use
RU2180581C1 (ru) Состав для лечения воспалительных и дегенеративных заболеваний опорно-двигательного аппарата
RU2237467C1 (ru) Крем для массажа

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA